Industry Perspectives
| 2 min read
Two new animal microphysiological system models have been introduced to improve the translatability of preclinical drug safety assessments by enabling early, comparative evaluation of hepatotoxicity across human, rat, and dog Liver-on-a-chip models.
| 3 min read
Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections
| 2 min read
Early detection test to be developed in collaboration with the Salford Royal NHS Foundation Trust and the Northern Care Alliance Research Collection biobank
| 7 min read
Unified data platforms are key to breaking down silos, improving data accessibility, and enabling more efficient, accurate, and predictive workflows across the drug development lifecycle.
| 3 min read
Agilent debuts LC/MS and GC/MS innovations at ASMS 2025, advancing lab efficiency, sustainability, and analytical performance.
| 3 min read
With the launch of the ZenoTOF 8600 system and new software partnerships, SCIEX advances accurate mass quantitation by delivering unprecedented sensitivity, speed, and data clarity across all omics disciplines.
| 3 min read
Orbitrap Astral Zoom and Orbitrap Excedion Pro deliver increased speed and sensitivity to set a new performance benchmark for high-resolution, accurate mass spectrometry.
| 4 min read
The timsOmni™ uniquely enables protein researchers and biologics developers to tailor information-rich dissociation pathways for deeper insights - with high speed and high sensitivity.
| 3 min read
The new system is designed to deliver exceptional performance for the most sensitive trace-level analyses in complex matrices, while maximizing system uptime and efficiency.
| 4 min read
The timsMetabo™ system enables the generation of a ‘digital metabolome archive’ for every sample.
| 5 min read
Recent advancements in imaging technologies are transforming spatial proteomics by enhancing data throughput, resolution, and multiplexing capabilities.
| 1 min read
Acquisition supports TQ Therapeutics’ development of ultra-short extracorporeal cell and gene therapy platform
